<p>Sensus Healthcare（纳斯达克代码：SRTS - 获取免费报告）于周四发布了季度财报。该公司报告本季度每股收益为（$0.16），低于市场共识预期的（$0.12）$0.04，Zacks 报道。该公司本季度的收入为 339 万美元，而分析师预期为 532 万美元。Sensus Healthcare 的股本回报率为负 15.11%，净利润率为负 28.09%。</p>
<p>获取 <strong>Sensus Healthcare</strong> 的提醒：</p>
<p>以下是 Sensus Healthcare 电话会议的关键要点：</p>
<ul>
<li>Sensus 表示，2026 年 1 月 1 日起生效的新专用 <strong>CPT 代码</strong> 实质性改善了报销——包括每次治疗代码约 <strong>300% 的增加</strong>——早期的 EOB 显示付款方正在处理索赔，管理层表示这推动了医生的更强兴趣和管道增长。</li>
<li>第一季度收入为 340 万美元，而去年同期为 830 万美元，主要是因为没有对公司历史上最大的客户进行销售；调整后的 EBITDA 为负 <strong>420 万美元</strong>，净亏损为 <strong>260 万美元</strong>，尽管管理层指出在排除该客户后仍有基础增长。</li>
<li>管理层优先考虑通过 <strong>Sensus Link</strong> 软件和公平交易/租赁计划（18 个活跃的公平交易地点，9 个待定）来实现经常性收入，并强调了一个可报销的每周放射物理代码（约$93.85/周），可以通过 Sensus Link 进行货币化并与客户分享。</li>
<li>商业扩展计划——第一季度发货 14 个系统（10 个直接，4 个公平交易/租赁），约 <strong>70% 的系统购买</strong> 发生在本季度，推出 <strong>Sensus Healthcare Financial Services</strong>，以及更强的会议驱动管道——支撑了管理层对第二季度/下半年收入增长和全年盈利能力的预期。</li>
</ul>
<h2>Sensus Healthcare 股票下跌 25.1%</h2>
<p>周五午盘交易中，SRTS 股票下跌$1.03，达到$3.08。该公司的股票交易量为 665,134 股，而其平均交易量为 84,977 股。Sensus Healthcare 的 52 周低点为$2.82，52 周高点为$5.92。该股票的市值为 5070 万美元，市盈率为-6.55，贝塔值为 1.19。该公司的 50 日简单移动平均为$4.14，200 日简单移动平均为$4.16。</p>
<h2>分析师评级变动</h2>
<p>几位分析师最近对该股票发表了看法。华尔街 Zen 在 2 月 14 日的报告中将 Sensus Healthcare 的股票评级从 “持有” 下调至 “卖出”。Maxim Group 在 2 月 17 日的研究报告中将 Sensus Healthcare 的目标价从$8.00 下调至$6.00，并对该股票给予 “买入” 评级。花旗集团在周五的研究报告中重新发布了对 Sensus Healthcare 的 “买入” 评级。Alliance Global Partners 在 3 月 6 日的研究报告中开始覆盖 Sensus Healthcare 的股票。他们对该股票设定了 “买入” 评级和$7.50 的目标价。最后，Weiss Ratings 在 4 月 21 日的研究报告中重新发布了对 Sensus Healthcare 的 “卖出（d）” 评级。五位投资分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat，该公司目前的共识评级为 “适度买入”，平均目标价为$6.88。</p>
<p><strong>查看我们关于 Sensus Healthcare 的最新研究报告</strong></p>
<h2>对 Sensus Healthcare 的对冲基金看法</h2>
<p>一些对冲基金和其他机构投资者最近买入和卖出了 SRTS 的股票。Geode Capital Management LLC 在第二季度将其在 Sensus Healthcare 的持股增加了 2.5%。Geode Capital Management LLC 目前拥有 153,917 股该公司的股票，价值 73 万美元，在上个季度购买了额外的 3,766 股。Jane Street Group LLC 在第四季度购买了 Sensus Healthcare 的新头寸，价值 79,000 美元。State Street Corp 在第四季度将其在 Sensus Healthcare 的持股增加了 5.2%。State Street Corp 目前拥有 69,252 股该公司的股票，价值 27.6 万美元，在上个季度购买了额外的 3,400 股。Ingalls &amp; Snyder LLC 在第四季度购买了 Sensus Healthcare 的新头寸，价值 21.9 万美元。最后，Greenline Wealth Management LLC 在第四季度购买了 Sensus Healthcare 的新头寸，价值 51.3 万美元。25.30% 的股票由机构投资者持有。</p>
<h2>关于 Sensus Healthcare</h2>
<p>（获取免费报告）</p>
<p>Sensus Healthcare, Inc 是一家医疗技术公司，专注于开发、制造和商业化表面放射治疗（SRT）系统。该公司的 SRT 设备利用低能 X 射线治疗多种皮肤病和肿瘤疾病，尤其是非黑色素瘤皮肤癌，如基底细胞癌和鳞状细胞癌，以及包括瘢痕疙瘩在内的良性病变。通过向表层组织层提供靶向辐射，Sensus Healthcare 的系统旨在为合格患者提供一种替代外科切除或系统治疗的非侵入性治疗选择。</p>
<p>该公司的旗舰产品包括 SRT-100™和 SRT-100+™平台，具有手持式应用器、可调能量设置和集成安全控制。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 Sensus Healthcare</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1JUUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1JUUw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Sensus Healthcare 吗？</h2>
<p>在你考虑 Sensus Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Sensus Healthcare 并不在名单上。</p>
<p>虽然 Sensus Healthcare 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Sensus医疗保健

美国医药设备 ETF - iShares

标普健康医疗设备 ETF - SPDR

<p>Sensus Healthcare（纳斯达克代码：SRTS）报告的季度收益为每股亏损 0.16 美元，低于预期 0.04 美元。收入为 339 万美元，低于预期的 532 万美元。该公司的净利润率为负 28.09%，股本回报率为负 15.11%。尽管结果令人失望，管理层预计由于新的报销代码和商业扩展计划，第二季度/下半年的收入将会增加。股价下跌 25.1%，至 3.08 美元，分析师将其评级为 “适度买入”，共识目标价为 6.88 美元</p>

<p>Sensus Healthcare (NASDAQ:SRTS - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.04), Zacks reports. The firm had revenue of $3.39 million for the quarter, compared to analyst estimates of $5.32 million. Sensus Healthcare had a negative return on equity of 15.11% and a negative net margin of 28.09%.</p>
<div class="lb-trans"><p>Sensus Healthcare（纳斯达克代码：SRTS - 获取免费报告）于周四发布了季度财报。该公司报告本季度每股收益为（$0.16），低于市场共识预期的（$0.12）$0.04，Zacks 报道。该公司本季度的收入为 339 万美元，而分析师预期为 532 万美元。Sensus Healthcare 的股本回报率为负 15.11%，净利润率为负 28.09%。</p>
</div><p>Get <strong>Sensus Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Sensus Healthcare</strong> 的提醒：</p>
</div><p>Here are the key takeaways from Sensus Healthcare's conference call:</p>
<div class="lb-trans"><p>以下是 Sensus Healthcare 电话会议的关键要点：</p>
</div><ul>
<li>Sensus says new dedicated <strong>CPT codes</strong> effective Jan 1, 2026 materially improve reimbursement — including about a <strong>300% increase</strong> in the per‑fraction delivery code — and early EOBs show payers are processing claims, which management says is driving stronger physician interest and pipeline growth.</li>
<li>Q1 revenue was $3.4 million versus $8.3 million a year ago primarily because there were no sales to the company's historically largest customer; adjusted EBITDA was negative <strong>$4.2 million</strong> and net loss was <strong>$2.6 million</strong>, though management notes underlying growth when excluding that customer.</li>
<li>Management is prioritizing recurring revenue through the <strong>Sensus Link</strong> software and the Fair Deal/rental program (18 active Fair Deal sites, 9 pending), and highlighted a reimbursable weekly radiation physics code (~$93.85/week) that can be monetized and shared with customers via Sensus Link.</li>
<li>Commercial expansion initiatives — 14 systems shipped in Q1 (10 direct, 4 Fair Deal/rental), ~ <strong>70% purchases</strong> of systems in the quarter, the launch of <strong>Sensus Healthcare Financial Services</strong>, and a stronger conference-driven pipeline — underpin management's expectation of higher Q2/H2 revenue and a path to full‑year profitability.</li>
</ul>
<div class="lb-trans"><ul>
<li>Sensus 表示，2026 年 1 月 1 日起生效的新专用 <strong>CPT 代码</strong> 实质性改善了报销——包括每次治疗代码约 <strong>300% 的增加</strong>——早期的 EOB 显示付款方正在处理索赔，管理层表示这推动了医生的更强兴趣和管道增长。</li>
<li>第一季度收入为 340 万美元，而去年同期为 830 万美元，主要是因为没有对公司历史上最大的客户进行销售；调整后的 EBITDA 为负 <strong>420 万美元</strong>，净亏损为 <strong>260 万美元</strong>，尽管管理层指出在排除该客户后仍有基础增长。</li>
<li>管理层优先考虑通过 <strong>Sensus Link</strong> 软件和公平交易/租赁计划（18 个活跃的公平交易地点，9 个待定）来实现经常性收入，并强调了一个可报销的每周放射物理代码（约$93.85/周），可以通过 Sensus Link 进行货币化并与客户分享。</li>
<li>商业扩展计划——第一季度发货 14 个系统（10 个直接，4 个公平交易/租赁），约 <strong>70% 的系统购买</strong> 发生在本季度，推出 <strong>Sensus Healthcare Financial Services</strong>，以及更强的会议驱动管道——支撑了管理层对第二季度/下半年收入增长和全年盈利能力的预期。</li>
</ul>
</div><h2>Sensus Healthcare Stock Down 25.1%</h2>
<div class="lb-trans"><h2>Sensus Healthcare 股票下跌 25.1%</h2>
</div><p>SRTS stock traded down $1.03 during midday trading on Friday, reaching $3.08. The company's stock had a trading volume of 665,134 shares, compared to its average volume of 84,977. Sensus Healthcare has a 52 week low of $2.82 and a 52 week high of $5.92. The stock has a market cap of $50.70 million, a PE ratio of -6.55 and a beta of 1.19. The business's 50-day simple moving average is $4.14 and its 200-day simple moving average is $4.16.</p>
<div class="lb-trans"><p>周五午盘交易中，SRTS 股票下跌$1.03，达到$3.08。该公司的股票交易量为 665,134 股，而其平均交易量为 84,977 股。Sensus Healthcare 的 52 周低点为$2.82，52 周高点为$5.92。该股票的市值为 5070 万美元，市盈率为-6.55，贝塔值为 1.19。该公司的 50 日简单移动平均为$4.14，200 日简单移动平均为$4.16。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Several analysts have recently weighed in on the stock. Wall Street Zen lowered shares of Sensus Healthcare from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a report on Saturday, February 14th. Maxim Group decreased their price target on shares of Sensus Healthcare from $8.00 to $6.00 and set a &#34;buy&#34; rating on the stock in a research note on Tuesday, February 17th. Citigroup reissued a &#34;buy&#34; rating on shares of Sensus Healthcare in a research note on Friday. Alliance Global Partners assumed coverage on shares of Sensus Healthcare in a research note on Friday, March 6th. They set a &#34;buy&#34; rating and a $7.50 price target on the stock. Finally, Weiss Ratings reissued a &#34;sell (d)&#34; rating on shares of Sensus Healthcare in a research note on Tuesday, April 21st. Five investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $6.88.</p>
<div class="lb-trans"><p>几位分析师最近对该股票发表了看法。华尔街 Zen 在 2 月 14 日的报告中将 Sensus Healthcare 的股票评级从 “持有” 下调至 “卖出”。Maxim Group 在 2 月 17 日的研究报告中将 Sensus Healthcare 的目标价从$8.00 下调至$6.00，并对该股票给予 “买入” 评级。花旗集团在周五的研究报告中重新发布了对 Sensus Healthcare 的 “买入” 评级。Alliance Global Partners 在 3 月 6 日的研究报告中开始覆盖 Sensus Healthcare 的股票。他们对该股票设定了 “买入” 评级和$7.50 的目标价。最后，Weiss Ratings 在 4 月 21 日的研究报告中重新发布了对 Sensus Healthcare 的 “卖出（d）” 评级。五位投资分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat，该公司目前的共识评级为 “适度买入”，平均目标价为$6.88。</p>
</div><p><strong>Check Out Our Latest Research Report on Sensus Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Sensus Healthcare 的最新研究报告</strong></p>
</div><h2>Hedge Funds Weigh In On Sensus Healthcare</h2>
<div class="lb-trans"><h2>对 Sensus Healthcare 的对冲基金看法</h2>
</div><p>A number of hedge funds and other institutional investors have recently bought and sold shares of SRTS. Geode Capital Management LLC boosted its position in shares of Sensus Healthcare by 2.5% during the second quarter. Geode Capital Management LLC now owns 153,917 shares of the company's stock worth $730,000 after purchasing an additional 3,766 shares in the last quarter. Jane Street Group LLC bought a new position in shares of Sensus Healthcare during the fourth quarter worth $79,000. State Street Corp boosted its position in shares of Sensus Healthcare by 5.2% during the fourth quarter. State Street Corp now owns 69,252 shares of the company's stock worth $276,000 after purchasing an additional 3,400 shares in the last quarter. Ingalls &amp; Snyder LLC bought a new position in shares of Sensus Healthcare during the fourth quarter worth $219,000. Finally, Greenline Wealth Management LLC bought a new position in shares of Sensus Healthcare during the fourth quarter worth $513,000. 25.30% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>一些对冲基金和其他机构投资者最近买入和卖出了 SRTS 的股票。Geode Capital Management LLC 在第二季度将其在 Sensus Healthcare 的持股增加了 2.5%。Geode Capital Management LLC 目前拥有 153,917 股该公司的股票，价值 73 万美元，在上个季度购买了额外的 3,766 股。Jane Street Group LLC 在第四季度购买了 Sensus Healthcare 的新头寸，价值 79,000 美元。State Street Corp 在第四季度将其在 Sensus Healthcare 的持股增加了 5.2%。State Street Corp 目前拥有 69,252 股该公司的股票，价值 27.6 万美元，在上个季度购买了额外的 3,400 股。Ingalls &amp; Snyder LLC 在第四季度购买了 Sensus Healthcare 的新头寸，价值 21.9 万美元。最后，Greenline Wealth Management LLC 在第四季度购买了 Sensus Healthcare 的新头寸，价值 51.3 万美元。25.30% 的股票由机构投资者持有。</p>
</div><h2>About Sensus Healthcare</h2>
<div class="lb-trans"><h2>关于 Sensus Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Sensus Healthcare, Inc is a medical technology company specializing in the development, manufacture and commercialization of superficial radiation therapy (SRT) systems. The company's SRT devices utilize low-energy X-rays to treat a range of dermatological and oncological conditions, most notably non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma, as well as benign lesions including keloids. By delivering targeted radiation to superficial tissue layers, Sensus Healthcare's systems aim to provide an alternative to surgical excision or systemic therapies, offering clinicians a non-invasive treatment option for eligible patients.</p>
<div class="lb-trans"><p>Sensus Healthcare, Inc 是一家医疗技术公司，专注于开发、制造和商业化表面放射治疗（SRT）系统。该公司的 SRT 设备利用低能 X 射线治疗多种皮肤病和肿瘤疾病，尤其是非黑色素瘤皮肤癌，如基底细胞癌和鳞状细胞癌，以及包括瘢痕疙瘩在内的良性病变。通过向表层组织层提供靶向辐射，Sensus Healthcare 的系统旨在为合格患者提供一种替代外科切除或系统治疗的非侵入性治疗选择。</p>
</div><p>The company's flagship products include the SRT-100™ and SRT-100+™ platforms, which feature handheld applicators, adjustable energy settings and integrated safety controls.</p>
<div class="lb-trans"><p>该公司的旗舰产品包括 SRT-100™和 SRT-100+™平台，具有手持式应用器、可调能量设置和集成安全控制。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Sensus Healthcare</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Sensus Healthcare</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1JUUw" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=SRTS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Sensus Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Sensus Healthcare 吗？</h2>
</div><p>Before you consider Sensus Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Sensus Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sensus Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Sensus Healthcare 并不在名单上。</p>
</div><p>While Sensus Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Sensus Healthcare 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Sensus 医疗保健（NASDAQ:SRTS）公布季度财报，每股收益比预期低 0.04 美元